1-4 of 4
Kim Hawkins, MSc
Close
Sort by
Journal Articles

Inherited Genetic Variation and the Risk of Developing Venous Thrombosis with Thalidomide Treatment in Myeloma Patients.

David C. Johnson, BSc, Suzanne Grindle, BS, Faith Davies, MD, David Gonzalez, PhD, Christine Ramos, PhD, Kim Hawkins, MSc, Suzanne Bell, PhD, Heather Kesby, BSc, S. Vincent Rajkumar, MD, Erik Rassmusen, PhD, John Crowley, PhD, Emily Blood, PhD, J. Anthony Child, MD, Brian G.M. Durie, MD, Brian G. Van Ness, PhD, Gareth J. Morgan, MDPhD
Journal: Blood
Blood (2005) 106 (11): 1624.
https://doi.org/10.1182/blood.V106.11.1624.1624
Published: 2005
Journal Articles

Quality of Life in the LRF CLL4 Trial.

Monica Else, MSc, Alastair G. Smith, MD, Kim Hawkins, MSc, Shirley Crofts, MSc, Margaret Course, BA, Susan Richards, D.Phil, Daniel Catovsky, MD DSc(Med)
Journal: Blood
Blood (2005) 106 (11): 2111.
https://doi.org/10.1182/blood.V106.11.2111.2111
Published: 2005
Journal Articles

Follow up Analysis for MRC Myeloma VII Trial.

Gareth J. Morgan, PhD, Faith E. Davies, MD, Kim Hawkins, MSc, Susan E. Bell, DPhil, Julia M. Brown, MSc, Roger G. Owen, MD, Mark T. Drayson, PhD, Peter J. Selby, MD, Anthony J. Child, MD, for the Medical Research Council Adult Leukaemia Working Party
Journal: Blood
Blood (2004) 104 (11): 927.
https://doi.org/10.1182/blood.V104.11.927.927
Published: 2004
Journal Articles

Newly Diagnosed Myeloma Pateints Are at Risk of Venous Thrombotic Events - High Risk Patients Need To Be Identified and Recieve Thromboprophylaxis: The MRC Experience.

Faith E. Davies, MD, J. Anthony Child, MD, Kim Hawkins, MSc, Susan Bell, DPhil, Julia Brown, MSc, Mark T. Drayson, PhD, Graham H. Jackson, PhD, Gareth J. Morgan, PhD
Journal: Blood
Blood (2004) 104 (11): 2395.
https://doi.org/10.1182/blood.V104.11.2395.2395
Published: 2004